You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information. Switch to the US site. 

  • The Share
  • Arjo B
  • 15 Nov 2018 18:00
  • 3.28 USD (-3.25%)

Arjo announces date of 2018 Q3 report and conference call

Arjo will issue its Q3 report for 2018 on Monday October 22nd at 13:15 CET, followed by a conference call at 14:00 CET, hosted by Joacim Lindoff, President & CEO, and Jonas Lindqvist, CFO.

We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference:

Swedish dial-in number: +46 (0)8 5065 3942
UK dial-in number: +44 (0)330 336 9411
US dial-in number: +1 323-794-2588
Participant passcode: 7702322

During the telephone conference, a presentation will be held. To access the presentation, please use this link: https://slideassist.webcasts.com/starthere.jsp?ei=1212492

Alternatively, use the following link to download the presentation:
https://www.arjo.com/int/about-us/investors/reports--presentations/2018/

Agenda

13:45             Call in to the conference
14:00             Review of the Q3 report
14.30             Q&A
15.00             End of conference

A recorded version of the conference is accessible for 90 days via the follwing link: https://slideassist.webcasts.com/starthere.jsp?ei=1212492

For more information, please contact:

 Kornelia Rasmussen, EVP Marketing Communications & Public Relations
Tel: +46(0)10 335 4810
E-mail: kornelia.rasmussen@arjo.com

Maria Nilsson, Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4866
Email: maria.nilsson@arjo.com

About Arjo

At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has about 6,000 employees worldwide and customers in over 100 countries. In 2017 the Arjo sales amounted to about SEK 7,7 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com

Download as PDF